A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity (PLLS)

Authors

Mark E. Gormley, Gillette Children's Specialty Healthcare, St. Paul, MN
Edward Dabrowski, Oakland University School of Medicine, Grosse Point, MI
Mauricio R. Delgado, University of Texas Southwestern Medical Center, Dallas, TX
Ann Tilton, LSU Health Sciences Center - New OrleansFollow
Asare Christian, Good Shepherd Rehabilitation Hospital, Allentown, PA
Sarah Helen Evans, Children's Hospital of Philadelphia, Philadelphia, PA
Francoise Calvi-Gries, Ipsen, Boulogne-Billancourt, France
Jumaah Goldberg, Ipsen, Cambridge, MA

Document Type

Conference Proceeding

Publication Date

10-21-2022

Publication Title

PM & R

Abstract

Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, AAPM and R 2022, October 20 - 23, 2022, Baltimore, MD

First Page

S176

Volume

14

Issue

Supplement 1

Rights

© 2022 American Academy of Physical Medicine and Rehabilitation.

Recommended Citation

Gormley, Mark E.; Dabrowski, Edward; Delgado, Mauricio R.; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Calvi-Gries, Francoise; and Goldberg, Jumaah, "A Phase IV, Prospective, Observational, Multicenter Study Evaluating the Effectiveness and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity (PLLS)" (2022). School of Medicine Faculty Publications. 4143.
https://digitalscholar.lsuhsc.edu/som_facpubs/4143
10.1002/pmrj.12913